Tag: medicine

Woman Develops Rare Acute Kidney Failure After First Dose of Pfizer Vaccine, Case Study Shows

A woman developed a rare case of acute kidney renal failure a few days after receiving her first dose of Pfizer-BioNTech’s COVID-19 vaccine. This vaccine injury adds to evidence that COVID-19 vaccines may promote the development of autoimmune diseases, or worsen existing cases. This article was originally published by The Defender – Children’s Health Defense’s…


Why You Should Avoid Osteoporosis Medications

About 34 million people in this country alone have low bone density and many over 60 have osteoporosis. But don’t expect bisphosphonate meds to strengthen your bones. Instead, they may raise your risk for fracture. Plus, most load-bearing exercises don’t provide enough of a load to help. STORY AT-A-GLANCE Internationally, osteoporosis affects 200 million women,…


Long COVID Contributing to Disabilities by the Millions

From early 2021, stories have emerged of people experiencing post-COVID-19 symptoms that were so debilitating it impacted their ability to work and live a normal life. Thirty-one-year-old Rebecca Meyer spoke on CNN in January 2021 about her 11-month struggle with long COVID symptoms for 11 months, having contracted symptoms from an infection. Prior to infection, she…


Inflammatory mRNA Nanoparticles Inhibits and Alters Immune Response: Pre-Print Study

A recent preprint study has shed light on why adverse events have been observed following a COVID-19 messenger RNA (mRNA) vaccination. The study, led by researchers from Thomas Jefferson University found that the lipid nanoparticles (LNPs) used to transport mRNA in COVID-19 vaccines could “inhibit” and “alter” immune responses in mice. LNPs are shells of lipids…


Inflammatory mRNA Nanoparticles Inhibit and Alter Immune Response: Pre-Print Study

A recent preprint study has shed light on why adverse events have been observed following a COVID-19 messenger RNA (mRNA) vaccination. The study, led by researchers from Thomas Jefferson University found that the lipid nanoparticles (LNPs) used to transport mRNA in COVID-19 vaccines could “inhibit” and “alter” immune responses in mice. LNPs are shells of lipids…


Why the COVID Jab Should Be Banned for Pregnant Women

Jab-maker Pfizer lied when they said their experimental COVID shots were harmless for women who are pregnant now, or might become pregnant in the future. Released data (which the FDA wanted buried for 75 years) tell a whole different story, with alarming news concerning males, females and unborn children. STORY AT-A-GLANCE Since the rollout of…


How Effective Is Your Cancer Medication? The Industry Might Not Even Know

Cancer is the second leading cause of death in the United States, right on the heels of heart disease. In developed countries, the general consensus is that if you do not die of heart disease, then the next likely event is cancer. In fact, most health experts expect that everyone will eventually develop, and likely…


New Zealand Secures Monkeypox Medicine, But Finds it Difficult to Get Vaccine Supply

The New Zealand government has announced it has secured a supply of tecovirimat, the medicine used to treat monkeypox, but was still working to secure a supply of the monkeypox vaccine, known as Jynneos or Imvanex. Associate Minister of Health Ayesha Verrall said that 504 courses of tecovirimat are expected to be available in the…


Untested Bivalent COVID Jab Being Rolled Out

Moderna’s newest bivalent booster shot has been given the green light in the UK – and will start going into arms as part of their autumn booster program. Too bad it includes strains that have mutated out of existence. STORY AT-A-GLANCE August 15, 2022, the U.K. became the first country to approve Moderna’s new bivalent…


FDA Finally Approved an Alzheimer’s Drug—But Everything Surrounding It Is Controversial

Analysis Aduhelm is the brand name under which the Alzheimer’s drug Aducanumab is marketed. It is developed by the U.S. company Biogen. The drug is to be administered as an intra-venous infusion every four weeks. The Food and Drug Administration (FDA) approved Aducanumab in June 2021, making it the first Alzheimer’s disease medication approved by the…